We are seeking a motivated individual who will study the tyrosine kinase BTK with regards to resistance mutations in cell line experiments and the tumour microenvironment in animal models.
Our group has expertise in the area of tyrosine kinases, especially the enzyme BTK, for which inhibitors are used as leukaemia treatment.
We are looking for an ambitious researcher to study BTK in both cell lines and in animal models.
The ideal candidate would be a motivated and team-oriented individual with strong English skills and a basic knowledge of in cell biology, including animal work. The research will involve laboratory work including cell culture, and animal studies, as well as various molecular biology techniques.
The candidate must:
A creative and inspiring environment with wide-ranging expertise and interests. Karolinska Institutet is one of the world's leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden. Karolinska Institutet is also a state university, which entitles you to several good benefits through our collective agreement. And you get to practice freely in our modern wellness facilities, where trained staff are on site.
Location: Flemingsberg
Choose to work at KI – Ten reasons why
Welcome to apply!
The application is to be submitted through the Varbi recruitment system. In this recruitment, you will apply with your CV without a personal letter. Instead, you will answer some questions about why you are applying for the job in the application form.
Type of employment | Special fixed-term employment |
---|---|
Contract type | Full time |
First day of employment | According to agreement |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Huddinge |
County | Stockholms län |
Country | Sweden |
Reference number | STÖD 2-4246/2024 |
Contact |
|
Union representative |
|
Published | 08.Nov.2024 |
Last application date | 22.Nov.2024 11:59 PM CET |